Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

K. Castro, J. Ward, L. Slutsker, et al.. (1993). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. Cited 4,249 times. https://doi.org/10.1093/CLINIDS/17.4.802

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

M. Dean, M. Carrington, Christoph Winkler, et al.. (1996). Science. Cited 2,690 times. https://doi.org/10.1126/science.273.5283.1856

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

S. Hammer, Kathleen Squires, M. Hughes, et al.. (1997). The New England journal of medicine. Cited 2,442 times. https://doi.org/10.1056/NEJM199709113371101

Data quality control in genetic case-control association studies

C. Anderson, F. Pettersson, G. Clarke, et al.. (2010). Nature Protocols. Cited 1,303 times. https://doi.org/10.1038/nprot.2010.116

Quality Control Procedures for Genome‐Wide Association Studies

Stephen D. Turner, L. Armstrong, Y. Bradford, et al.. (2011). Current Protocols in Human Genetics. Cited 389 times. https://doi.org/10.1002/0471142905.hg0119s68

Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

M. Robert-Guroff, S. H. Weiss, J. Girón, et al.. (1986). JAMA. Cited 324 times. https://doi.org/10.1001/JAMA.1986.03370220095034

Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members.

J. Goedert, R. Biggar, S. H. Weiss, et al.. (1986). Science. Cited 264 times. https://doi.org/10.1126/SCIENCE.3003917

The AIDS epidemic.

Sheldon H. Landesman, Harold M. Ginzburg, Stanley H. Weiss. (1985). The New England journal of medicine. Cited 208 times. https://doi.org/10.1056/NEJM198502213120829

HTLV-III infection among health care workers. Association with needle-stick injuries.

S. H. Weiss, W. Saxinger, D. Rechtman, et al.. (1985). JAMA. Cited 187 times. https://doi.org/10.1001/JAMA.1985.03360150065025

Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers.

Stanley H. Weiss, J. Goedert, Suzanne Gartner, et al.. (1988). Science. Cited 175 times. https://doi.org/10.1126/SCIENCE.3336776

Epidemiology and long term prognosis of hepatitis C virus infection in Japan.

M. Yano, H. Yatsuhashi, O. Inoue, et al.. (1993). Gut. Cited 136 times. https://doi.org/10.1136/GUT.34.2_SUPPL.S13

Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.

Helen H. Lee, S. H. Weiss, L. Brown, et al.. (1990). The Journal of infectious diseases. Cited 90 times. https://doi.org/10.1093/INFDIS/162.2.347

Distinguishing between HTLV-I and HTLV-II by western blot

S. Wiktor, Steve Alexander, GeorgeM. Shaw, et al.. (1990). The Lancet. Cited 80 times. https://doi.org/10.1016/0140-6736(90)93078-4

Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.

S. H. Weiss, J. Goedert, M. Sarngadharan, et al.. (1985). JAMA. Cited 77 times. https://doi.org/10.1001/jama.253.2.221

Recommendations for Choosing the Genotyping Method and Best Practices for Quality Control in Crop Genome-Wide Association Studies

Stefano Pavan, Chiara Delvento, L. Ricciardi, et al.. (2020). Frontiers in Genetics. Cited 76 times. https://doi.org/10.3389/fgene.2020.00447

Soft Tissue Infections in Parenteral Drug Abusers

G. Orangio, S. Pitlick, P. D. Latta, et al.. (1984). Annals of Surgery. Cited 74 times. https://doi.org/10.1097/00000658-198401000-00016

Links between cocaine and retroviral infection.

S. H. Weiss. (1989). JAMA. Cited 58 times. https://doi.org/10.1001/JAMA.1989.03420040145035

HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.

Robert J. Battjes, Roy W. Pickens, Lawrence S. Brown. (1995). Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. Cited 53 times. https://doi.org/10.1097/00042560-199509000-00013

Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.

Briggs Nc, Battjes Rj, Battjes Rj, et al.. (1995). The Journal of infectious diseases. Cited 53 times. https://doi.org/10.1093/INFDIS/172.1.51

Mycoplasma genitalium infection and host antibody immune response in patients infected by HIV, patients attending STD clinics and in healthy blood donors.

R. Y. Wang, T. Grandinetti, J. Shih, et al.. (2006). FEMS immunology and medical microbiology. Cited 53 times. https://doi.org/10.1111/J.1574-695X.1997.TB01093.X

Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

A. Beretta, S. Weiss, G. Rappocciolo, et al.. (1996). The Journal of infectious diseases. Cited 53 times. https://doi.org/10.1093/INFDIS/173.2.472

Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA

J. Goedert, Michael W. Fung, S. Felton, et al.. (2001). AIDS. Cited 51 times. https://doi.org/10.1097/00002030-200107060-00012

Hepatitis C virus load and survival among injection drug users in the United States

M. Hisada, N. Chatterjee, Z. Kalaylioglu, et al.. (2005). Hepatology. Cited 43 times. https://doi.org/10.1002/hep.20938

Human T lymphotropic virus type I antibody patterns: evidence of difference by age and risk group.

Gerard Agius, R. Biggar, Steve S. Alexander, et al.. (1988). The Journal of infectious diseases. Cited 36 times. https://doi.org/10.1093/INFDIS/158.6.1235

Ancient Tides and Length of Day: Correction

Philip Lader. (1996). Science. Cited 36 times. https://doi.org/10.1126/SCIENCE.274.5290.1069A

Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.

S. H. Weiss, Carol B. Weston, J. Quirinale. (1993). AIDS education and prevention : official publication of the International Society for AIDS Education. Cited 33 times. https://doi.org/10.1521/aeap.1993.5.4.279

Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.

M. Hisada, N. Chatterjee, Mingdong Zhang, et al.. (2003). The Journal of infectious diseases. Cited 31 times. https://doi.org/10.1086/377585

Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II.

A. Heredia, V. Soriano, Stanley H. Weiss, et al.. (1996). Clinical and diagnostic virology. Cited 31 times. https://doi.org/10.1016/S0928-0197(96)00255-3

HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities.

R. Battjes, R. Pickens, Z. Amsel. (1991). Journal of acquired immune deficiency syndromes. Cited 29 times.

Spontaneous lymphocyte proliferation in HTLV-II infection

S. Wiktor, W. Blattner, S. Jacobson, et al.. (1991). The Lancet. Cited 28 times. https://doi.org/10.1016/0140-6736(91)90947-N

HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users.

K. Cantor, S. H. Weiss, J. Goedert, et al.. (1991). Journal of acquired immune deficiency syndromes. Cited 26 times.

Exposure Factors for HIV-1 Infection Among Heterosexual Drug Abusers in New Jersey Treatment Programs

Deoraj Caussy, Stanley H. Weiss, W. Blattner, et al.. (1990). AIDS Research and Human Retroviruses. Cited 25 times. https://doi.org/10.1089/aid.1990.6.1459

The evolving epidemiology of human T lymphotropic virus type II.

S. Weiss. (1994). The Journal of infectious diseases. Cited 24 times. https://doi.org/10.1093/INFDIS/169.5.1080

Infections in parenteral drug abusers. Further immunologic studies.

G. Orangio, P. Della Latta, C. Marino, et al.. (1983). American journal of surgery. Cited 21 times. https://doi.org/10.1016/0002-9610(83)90330-6

Evaluation of human T cell lymphotropic virus infection in a cohort of injecting drug users.

P. Palumbo, S. Weiss, B. McCreedy, et al.. (1992). The Journal of infectious diseases. Cited 17 times. https://doi.org/10.1093/INFDIS/166.4.896

AIDS in Haitian-Americans: a reassessment.

E. Frank, S. H. Weiss, J. C. Compas, et al.. (1985). Cancer research. Cited 12 times.

LESSER AIDS AND TUBERCULOSIS

J. Goedert, S. Weiss, R. Biggar, et al.. (1985). The Lancet. Cited 12 times. https://doi.org/10.1016/S0140-6736(85)90112-6

Partial Resistance to Infection by R5X4 Primary HIV Type 1 Isolates in an Exposed-Uninfected Individual Homozygous for CCR5 32-Base Pair Deletion

Lihua Xiao, S. H. Weiss, S. Qari, et al.. (1999). AIDS Research and Human Retroviruses. Cited 10 times. https://doi.org/10.1089/088922299310296

Cross-sectional study of immunologic abnormalities in intravenous drug abusers on methadone maintenance in New York City.

M. Grieco, M. Reddy, C. Fusillo, et al.. (1989). AIDS. Cited 5 times. https://doi.org/10.1097/00002030-198904000-00007

Idiopathic CD4+ T-lymphocytopenia.

S. Weiss, C. Klein, R. Mayur, et al.. (1992). Lancet. Cited 3 times.

Absence of evidence of retrovirus infection in intravenous drug users with idiopathic CD4+ lymphocytopenia.

A. Heredia, B. Joshi, S. Weiss, et al.. (1994). The Journal of infectious diseases. https://doi.org/10.1093/INFDIS/170.3.748